Timelines of translational science: From technology initiation to FDA approval.
While timelines for clinical development have been extensively studied, there is little data on the broader path from initiation of research on novel drug targets, to approval of drugs based on this research. We examined timelines of translational science for 138 drugs and biologicals approved by th...
Main Authors: | Laura M McNamee, Michael Jay Walsh, Fred D Ledley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5421779?pdf=render |
Similar Items
-
Modeling timelines for translational science in cancer; the impact of technological maturation.
by: Laura M McNamee, et al.
Published: (2017-01-01) -
Translational science by public biotechnology companies in the IPO "class of 2000": the impact of technological maturity.
by: Laura McNamee, et al.
Published: (2013-01-01) -
Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
by: Su Min Cho, et al.
Published: (2022-05-01) -
As Technologies for Nucleotide Therapeutics Mature, Products Emerge
by: Jennifer M. Beierlein, et al.
Published: (2017-12-01) -
Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples.
by: Natalia A Petushkova, et al.
Published: (2017-01-01)